91Ó°ÊÓ

Statistical significance is one of the key concepts in hypothesis testing. It helps us determine if an effect observed in a study is likely to be real or if it could have happened by chance. In simpler terms, it's about understanding whether the differences in your findings are meaningful or if they could just be random variations.

In hypothesis testing, a significance level (often denoted as \(\alpha\)) is predetermined. Commonly, a significance level of \(0.05\) is used, which means there's a 5% chance of concluding that there is a difference when there isn't one, known as a Type I error. If the p-value obtained from the statistical test is less than \(0.05\), the result is considered statistically significant.

For the vaccine effectiveness study, after calculating the test statistic using a z-test, if the p-value is less than \(0.05\), we reject the null hypothesis. This implies that the vaccine is indeed effective, showing a lower proportion of virus cases than the placebo group. Therefore, achieving statistical significance here confirms that the difference in virus contraction rates between the vaccine and placebo groups is unlikely to have occurred by chance.

Sample proportion is a vital concept in conducting statistical analysis, especially when comparing different groups. It represents the fraction of the subjects in a sample that exhibit a particular characteristic.

In this vaccine study, the sample proportion tells us the percentage of children who contracted the virus in each of the two groups: those who were administered the vaccine and those given a placebo. You calculate it by dividing the number of children in each group who got the virus by the total number of children in the group.

• For the vaccine group: 63 children out of 3298 got the virus, resulting in a sample proportion of \(0.0191\) or 1.91%.
• For the placebo group: 80 children out of 1641 got the virus, resulting in a sample proportion of \(0.0487\) or 4.87%.

These sample proportions are crucial as they set the groundwork for comparing the effectiveness of the vaccine. By looking at these percentages, investigators can see if the vaccine group has a lower infection rate compared to the placebo group, which is desirable.

Random assignment is a fundamental component of the experimental design, ensuring that each participant has an equal chance of being placed in any given group. This method eliminates selection bias, which might otherwise skew the results.

During the vaccine study, children were randomly assigned to either receive the vaccine or a placebo. This randomization ensures that any observed differences in the virus contraction rates between these groups can be attributed to the vaccine rather than external factors.

Moreover, random assignment strengthens the validity of the experiment by ensuring that both groups are comparable in all respects except for the intervention they receive (vaccine or placebo). This is vital for confidently attributing any difference in outcomes to the vaccine itself rather than other variables, which might have confounded the results if participants were not randomly assigned.